1. Home
  2. RCUS vs GSM Comparison

RCUS vs GSM Comparison

Compare RCUS & GSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCUS
  • GSM
  • Stock Information
  • Founded
  • RCUS 2015
  • GSM 2015
  • Country
  • RCUS United States
  • GSM United Kingdom
  • Employees
  • RCUS N/A
  • GSM N/A
  • Industry
  • RCUS Biotechnology: Pharmaceutical Preparations
  • GSM Metal Mining
  • Sector
  • RCUS Health Care
  • GSM Basic Materials
  • Exchange
  • RCUS Nasdaq
  • GSM Nasdaq
  • Market Cap
  • RCUS 727.1M
  • GSM 739.5M
  • IPO Year
  • RCUS 2018
  • GSM N/A
  • Fundamental
  • Price
  • RCUS $8.28
  • GSM $3.74
  • Analyst Decision
  • RCUS Buy
  • GSM Hold
  • Analyst Count
  • RCUS 11
  • GSM 1
  • Target Price
  • RCUS $25.33
  • GSM N/A
  • AVG Volume (30 Days)
  • RCUS 1.2M
  • GSM 940.4K
  • Earning Date
  • RCUS 05-06-2025
  • GSM 05-07-2025
  • Dividend Yield
  • RCUS N/A
  • GSM 1.34%
  • EPS Growth
  • RCUS N/A
  • GSM N/A
  • EPS
  • RCUS N/A
  • GSM N/A
  • Revenue
  • RCUS $141,000,000.00
  • GSM $1,559,264,000.00
  • Revenue This Year
  • RCUS N/A
  • GSM N/A
  • Revenue Next Year
  • RCUS $25.77
  • GSM $6.90
  • P/E Ratio
  • RCUS N/A
  • GSM N/A
  • Revenue Growth
  • RCUS N/A
  • GSM N/A
  • 52 Week Low
  • RCUS $6.50
  • GSM $2.97
  • 52 Week High
  • RCUS $18.98
  • GSM $6.19
  • Technical
  • Relative Strength Index (RSI)
  • RCUS 48.63
  • GSM 58.67
  • Support Level
  • RCUS $7.06
  • GSM $3.04
  • Resistance Level
  • RCUS $9.35
  • GSM $3.62
  • Average True Range (ATR)
  • RCUS 0.55
  • GSM 0.16
  • MACD
  • RCUS 0.06
  • GSM 0.02
  • Stochastic Oscillator
  • RCUS 53.28
  • GSM 89.74

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About GSM Ferroglobe PLC

Ferroglobe PLC provides silicon-based alloys and specialty metals. It produces silicon metal and silicon and manganese-based alloy, serving customers in the specialty chemical, aluminum, solar, steel and ductile iron foundry industries. The company's business segments include North America - Silicon; Europe - Manganese; Europe - Silicon; South Africa - Silicon and Other segments The primary raw materials company uses to produce its electrometallurgy products includes its coal and quartz mining operations and its silicon metal and ferroalloy production.

Share on Social Networks: